Pharmaceuticals
-
NICE calls for more people to be offered statins
More people in England could be offered statins, following newly published draft guidance from NICE. Read more
-
Cough medicine treatment for Parkinson’s disease trial
A £5.5 million phase III trial is to begin in the UK this year, studying whether a cough medicine can help to slow down the progression of Parkinson’s disease. Read more
-
England to get somatrogon for growth hormone deficiency
Children being treated for growth disturbance could be treated with injections weekly instead of daily, according to new guidance. Read more
-
Nasal COVID antibodies short-lived
The next generation of COVID vaccines should include nasal sprays because other vaccines have limited impact on protective levels in the nose, British researchers have suggested. Read more
-
Newborns not at higher risk of being colonised by hospital pathogens
Healthy newborn babies are not at higher risk than adults of being colonised by antimicrobial-resistant gut bacteria in hospital, a new study has found. Read more
-
Vaping alongside doesn’t help smoking cessation
People who vape but continue to use tobacco products are unlikely to give up smoking, according to research published today. Read more
-
Insight into time of day effect of vaccines
The circadian clock influences response to vaccines, with immune cells behaving differently depending on the time of day, according to a new analysis. Read more
-
Off-patent drug ‘an important weapon’ against COVID-19
An off-patent drug that is used to treat liver disease could be an “important weapon” against COVID-19, according to a new study published last night. Read more
-
Long road ahead for promising Alzheimer’s drug
There is a “long way to go” before a new Alzheimer’s disease drug becomes available on the NHS after a clinical trial showed it delaying early memory loss, experts say. Read more
-
Virus evolution insights may boost gene therapy
Study of the evolution of viruses in mammals over millions of years may improve the use of viral vectors for gene therapy, researchers have announced. Read more